178 related articles for article (PubMed ID: 30775317)
1. Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma.
Gao Y; Liu B; Feng L; Sun B; He S; Yang Y; Wu G; E G; Liu C; Gao Y; Zhang E; Zhu B
Front Oncol; 2019; 9():33. PubMed ID: 30775317
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma.
Gao Y; Zhang E; Liu B; Zhou K; He S; Feng L; Wu G; Cao M; Wu H; Cui Y; Zhang X; Liu X; Wang Y; Gao Y; Bian X
J Cell Mol Med; 2019 Sep; 23(9):6228-6237. PubMed ID: 31282108
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
Agrawal R; Pandey P; Jha P; Dwivedi V; Sarkar C; Kulshreshtha R
BMC Genomics; 2014 Aug; 15(1):686. PubMed ID: 25129238
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Targeting JUN, CEBPB and HDAC3: a novel strategy to overcome drug resistance in hypoxic glioblastoma.
Gao Y; Liu B; Feng L; Sun B; He S; Yang Y; Wu G; E G; Liu C; Gao Y; Zhang E; Zhu B
Front Oncol; 2024; 14():1392899. PubMed ID: 38715787
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma.
Gao Y; Liu B; Feng L; Sun B; He S; Yang Y; Wu G; E G; Liu C; Gao Y; Zhang E; Zhu B
Front Oncol; 2020; 10():644. PubMed ID: 32411606
[TBL] [Abstract][Full Text] [Related]
6. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia Transcriptomic Modifications Induced by Proton Irradiation in U87 Glioblastoma Multiforme Cell Line.
Bravatà V; Tinganelli W; Cammarata FP; Minafra L; Calvaruso M; Sokol O; Petringa G; Cirrone GAP; Scifoni E; Forte GI; Russo G
J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33923454
[TBL] [Abstract][Full Text] [Related]
9. An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by Metformin.
Calvo Tardón M; Marinari E; Migliorini D; Bes V; Tankov S; Charrier E; McKee TA; Dutoit V; Dietrich PY; Cosset E; Walker PR
Biology (Basel); 2020 Sep; 9(9):. PubMed ID: 32887267
[TBL] [Abstract][Full Text] [Related]
10. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy.
Ho KH; Shih CM; Liu AJ; Chen KC
Cancer Sci; 2022 Feb; 113(2):540-552. PubMed ID: 34897892
[TBL] [Abstract][Full Text] [Related]
12. Preservation of the Hypoxic Transcriptome in Glioblastoma Patient-Derived Cell Lines Maintained at Lowered Oxygen Tension.
Gozdz A; Wojtaś B; Szpak P; Szadkowska P; Czernicki T; Marchel A; Wójtowicz K; Kaspera W; Ladzinski P; Szopa W; Niedbala M; Nawrocki S; Kaminska B; Kalaszczynska I
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230775
[TBL] [Abstract][Full Text] [Related]
13. Profiling and Bioinformatics Analyses of Hypoxia-Induced Differential Expression of Long Non-coding RNA in Glioblastoma Multiforme Cells.
Cai X; Qian M; Zhang K; Li Y; Chang B; Chen M
Biochem Genet; 2023 Dec; ():. PubMed ID: 38066404
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
15. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
Wang K; Lu Y; Liu Z; Diao M; Yang L
Biomed Res Int; 2022; 2022():7858477. PubMed ID: 35155681
[TBL] [Abstract][Full Text] [Related]
16. Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma.
Tafani M; Di Vito M; Frati A; Pellegrini L; De Santis E; Sette G; Eramo A; Sale P; Mari E; Santoro A; Raco A; Salvati M; De Maria R; Russo MA
J Neuroinflammation; 2011 Apr; 8():32. PubMed ID: 21489226
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-Driven M2-Polarized Macrophages Facilitate Cancer Aggressiveness and Temozolomide Resistance in Glioblastoma.
Zhang G; Tao X; Ji B; Gong J
Oxid Med Cell Longev; 2022; 2022():1614336. PubMed ID: 36046687
[TBL] [Abstract][Full Text] [Related]
18. LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt/β-catenin signaling.
Lu Y; Tian M; Liu J; Wang K
J Biochem Mol Toxicol; 2021 Sep; 35(9):e22848. PubMed ID: 34328678
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic switch leads to a metabolic shift in human glioblastoma.
Talasila KM; Røsland GV; Hagland HR; Eskilsson E; Flønes IH; Fritah S; Azuaje F; Atai N; Harter PN; Mittelbronn M; Andersen M; Joseph JV; Hossain JA; Vallar L; Noorden CJ; Niclou SP; Thorsen F; Tronstad KJ; Tzoulis C; Bjerkvig R; Miletic H
Neuro Oncol; 2017 Mar; 19(3):383-393. PubMed ID: 27591677
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
